PMDA drug package insert
コバシル錠2mg
PMDA Prescription drug · 協和キリン株式会社 · package insert Sep 9, 2025
Key facts
| Brand names | コバシル錠2mg, コバシル錠4mg |
|---|---|
| Nonproprietary names | ペリンドプリルエルブミン |
| Companies | 製造販売元／協和キリン株式会社, 提携／レ ラボラトワール セルヴィエ フランス |
| Product type | Prescription drug |
| Therapeutic category | 高血圧症治療剤（持続性組織ACE阻害剤） |
| Therapeutic category codes | 872144 |
| YJ codes | 2144012F1028, 2144012F2024 |
| Approval numbers | 21000AMZ00114, 21000AMZ00115 |
| Package insert edition | 第3版 |
| Package insert date | Sep 9, 2025 |
| PMDA document key | 230124_2144012F1028_3 |
| PMDA company code | 230124 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: